| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 16 |
| 1 | METHOTREXATE SODIUM | 16 |
| 2 | THIOTEPA | 16 |
| 3 | ETOPOSIDE | 15 |
| 4 | METHOTREXATE | 15 |
| 5 | CISPLATIN | 14 |
| 6 | CYCLOPHOSPHAMIDE | 13 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 9 | VINCRISTINE SULFATE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THIOTEPA | 16 | 0.0016 |
| 1 | DIAZOXIDE | 1 | 0.0014 |
| 2 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 3 | NITRIC OXIDE | 2 | 0.0004 |
| 4 | VINCRISTINE SULFATE | 10 | 0.0003 |
| 5 | ENFORTUMAB VEDOTIN | 2 | 0.0003 |
| 6 | ETOPOSIDE | 15 | 0.0002 |
| 7 | CISPLATIN | 14 | 0.0002 |
| 8 | ACLIDINIUM BROMIDE | 1 | 0.0002 |
| 9 | AZTREONAM | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 17 |
| 1 | Platinum-based Drug [EPC] | 17 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 15 |
| 3 | Topoisomerase Inhibitor [EPC] | 15 |
| 4 | Endothelin Receptor Antagonist [EPC] | 6 |
| 5 | Corticosteroid [EPC] | 5 |
| 6 | Antirheumatic Agent [EPC] | 2 |
| 7 | Factor Xa Inhibitor [EPC] | 2 |
| 8 | Insulin Analog [EPC] | 2 |
| 9 | Phosphodiesterase 5 Inhibitor [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Topoisomerase Inhibitor [EPC] | 15 | 0.0002 |
| 2 | Vitamin K [EPC] | 1 | 0.0001 |
| 3 | Anti-anginal [EPC] | 1 | 0.0001 |
| 4 | Barbiturate [EPC] | 1 | 0.0001 |
| 5 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 17 | 0.0001 |
| 7 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 17 | 0.0001 |
| 9 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |